Tempus AI (NASDAQ:TEM) Trading 3.5% Higher – Time to Buy?

Tempus AI, Inc. (NASDAQ:TEM)’s stock price shot up 3.5% on Friday . The stock traded as high as $49.40 and last traded at $49.72. 2,849,544 shares traded hands during trading, a decline of 43% from the average session volume of 5,025,887 shares. The stock had previously closed at $48.04.

Wall Street Analyst Weigh In

Several research firms have weighed in on TEM. William Blair restated a “market perform” rating on shares of Tempus AI in a report on Tuesday, February 25th. Morgan Stanley raised their target price on shares of Tempus AI from $50.00 to $60.00 and gave the company an “overweight” rating in a report on Thursday, March 6th. Guggenheim reiterated a “buy” rating on shares of Tempus AI in a report on Tuesday, February 25th. Piper Sandler lowered their price target on shares of Tempus AI from $70.00 to $55.00 and set a “neutral” rating for the company in a report on Tuesday, March 4th. Finally, Bank of America lifted their price target on shares of Tempus AI from $54.00 to $60.00 and gave the stock a “neutral” rating in a report on Monday, March 3rd. Six analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $61.18.

Tempus AI Stock Performance

The company’s 50-day moving average is $56.35 and its 200-day moving average is $51.39. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55.

Insider Buying and Selling

In other Tempus AI news, EVP Andrew Polovin sold 13,135 shares of Tempus AI stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $45.98, for a total transaction of $603,947.30. Following the transaction, the executive vice president now directly owns 154,171 shares of the company’s stock, valued at $7,088,782.58. The trade was a 7.85 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director David R. Epstein sold 990 shares of Tempus AI stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $46.83, for a total transaction of $46,361.70. Following the transaction, the director now directly owns 26,284 shares in the company, valued at approximately $1,230,879.72. This trade represents a 3.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 5,598,969 shares of company stock valued at $317,194,162.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Operose Advisors LLC acquired a new position in Tempus AI during the fourth quarter valued at approximately $25,000. First Horizon Advisors Inc. acquired a new position in shares of Tempus AI during the third quarter worth $30,000. Farther Finance Advisors LLC acquired a new position in shares of Tempus AI during the fourth quarter worth $34,000. Prestige Wealth Management Group LLC lifted its position in shares of Tempus AI by 910.4% during the fourth quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock worth $36,000 after purchasing an additional 965 shares in the last quarter. Finally, NewEdge Advisors LLC acquired a new position in shares of Tempus AI during the fourth quarter worth $49,000. 24.22% of the stock is owned by institutional investors and hedge funds.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.